Immunofluorescence analysis of tumors demonstrated that cisplatin reduced the percentage of cells positive for the proliferation marker, Ki67/mib-1 and increased cells showing expression of the apoptosis marker, cleaved caspase-3 (Fig. 3a and b), consistent with effects on tumor burden. Here, MIB1 is linked to neoplasm.